International regulators discuss available knowledge supporting COVID-19 medicine development

EMA

3 April 2020 - On 2 April, regulators from around the world joined the second workshop on COVID-19 organised by the EMA under the umbrella of the International Coalition of Medicines Regulatory Authorities.

Participants from more than 25 countries, representing 28 medicines regulatory authorities globally and experts from the World Health Organization and the European Commission discussed the available knowledge on possible treatments (drugs and biologics) for COVID-19, including:

  • Progress on COVID-19 medicine development
  • Availability of potential COVID-19 treatments
  • Ongoing and planned clinical trials
  • Compassionate use and off-label use of medicines in the context of COVID-19

Read EMA press release

Michael Wonder

Posted by:

Michael Wonder